Occurrence and identification of chalcones from the culinary-medicinal cauliflower mushroom Sparassis crispa (Wulf.) Fr. (Aphyllophoromycetideae)

International Journal of Medicinal Mushrooms

Volumn 10, Issue 4, 2008, Pages 331-336

  Kodani, Shinya ^a   Hayashi, Kanako ^a   Tokuyama, Sinji ^a   Hashimoto, Mamiko ^b   Kimura, Takashi ^b   Dombo, Munehiko ^b   Kawagishi, Hirokazu ^a  

^a SHIZUOKA UNIVERSITY   (Japan)

^b UNITIKA LTD   (Japan)

Author keywords

Chalcone; Medicinal mushrooms; MRSA; MS; NMR; Sparassis crispa

Indexed keywords

4 HYDROXYDERRICIN; CHALCONE DERIVATIVE; UNCLASSIFIED DRUG; XANTHOANGELOL;

ANGELICA KEISKEI; ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG ISOLATION; MASS SPECTROMETRY; MEDICINAL MUSHROOM; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUSHROOM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; SPARASSIS CRISPA;

ANGELICA KEISKEI; BASIDIOMYCOTA; BRASSICA OLERACEA VAR. BOTRYTIS; FUNGI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; SPARASSIS CRISPA;

EID: 53649100404     PISSN: 15219437     EISSN: None     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v10.i4.50     Document Type: Article

References (13)

1. Tada R, Harada T, Nagi-Miura N, Adachi Y, Nakajima M, Yadomae T, Ohno N. NMR characterization of the structure of a beta-(1→3)-D-glucan isolate from cultured fruit bodies of Sparassis crispa. Carbohydr Res. 2007;342:2611-8.
2. Woodward S, Sultan HY, Barrett DK, Pearce RB. Two new antifungal metabolites produced by Sparassis crispa in culture and in decayed trees. J Gen Microbiol. 1993;139:153-9.
3. Kawagishi H, Hayashi K, Tokuyama S, Hashimoto N, Kimura T, Dombo M. Novel bioactive compound from the Sparassis crispa mushroom. Biosci Biotechnol Biochem. 2007;71:1804-6.
4. Harada T, Miura NN, Adachi Y, Nakajima M, Yadomae T.Ohno N. IFN-gamma induction by SCG, 1,3-beta-Dglucan from Sparassis crispa, in DBA/2 mice in vitro. J Interferon Cytokine Res. 2002;22:1227-39.
5. Harada T, Kawaminami H, Miura NN, Adachi Y, Nakajima M, Yadomae T, Ohno N. Cell to cell contact through ICAM-1-LFA-1 and TNF-alpha synergistically contributes to GM-CSF and subsequent cytokine synthesis in DBA/2 mice induced by 1,3-beta-D-glucan SCG. J Interferon Cytokine Res. 2006;26:235-47.
6. Harada T, Kawaminami H, Miura NN, Adachi Y, Nakajima M, Yadomae T, Ohno N. Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice. Microbiol Immunol. 2006;50:687-700.
7. Okuyama T, Takata M, Takayasu J, Hasegawa T, Tokuda H, Nishino A, Nishino H, Iwashima A. Anti-tumor-promotion by principles obtained from Angelica keiskei. Planta Med. 1991;57:242-6.
8. Goncalves de Lima O, de Mello JF, de Barros Coelho JS, de Andrade Lyra FD, Machado de Albuquerque M, Marini-Bettolo GB, Delle Monache G, Delle Monache F. New prenylated chalcones from Lonchocarpus neuroscapha Benth. (Cordoa piaca). Farmaco [Sci]. 1975;30:326-42.
9. Kimura Y, Baba K. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: isolation of an active substance, xanthoangelol. Int J Cancer. 2003;106:429-37.
10. Epifano F, Genovese S, Menghini L, Curini M. Chemistry and pharmacology of oxyprenylated secondary plant metabolites. Phytochemistry. 2007;68:939-53.
11. Kimura Y, Taniguchi M, Baba K. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots. Planta Med. 2004;70:211-9.
12. + channel blocker. Bioorg Med Chem Lett. 2008;18:137-40.
13. Nishimura R, Tabata K, Arakawa M, Ito Y, Kimura Y, Akihisa T, Nagai H, Sakuma A, Kohno H, Suzuki T. Isobavachalcone, a chalcone constituent of Angelica keiskei, induces apoptosis in neuroblastoma. Biol Pharm Bull. 2007;30:1878-83.